The appointment of Luis Malaver-Ortega as R&D Manager is...

The appointment of Luis Malaver-Ortega as R&D Manager is interesting given the direction that SYC is heading. It would make for a pleasant surprise for the co. to unveil something in the area of what it has been doing all this time with OmniCAR. Collabs with CSIRO and LaTrobe but not a skerrick of newsflow.

My guess is that the learnings from our collab with Thermo Fisher meant opening other doors towards RNA technology and gene editing. I just hope that Steven's new position wasn't feathered at PTX's expense but has garnered valuable R&D for our platforms and maturing IP that's across numerous patent offices. Gavin Shepherd's appointment to the board suggests that this may be the case.

As for the lack of marketing... well that's been sh!te and not to mention the short notice and crap schedule of today's webinar.